Day: March 16, 2026

LYB names David Dennison as head of investor relations; Dave Kinney to retire

Written by Customer Service on March 16, 2026. Posted in Dividend Reports And Estimates.

HOUSTON and LONDON, March 16, 2026 (GLOBE NEWSWIRE) — LyondellBasell (NYSE: LYB) today announced the appointment of David Dennison, a seasoned leader with decades-long service at LYB, as the new head of investor relations, effective May 8, 2026. He succeeds Dave Kinney, who will retire after nearly 35 years of service. “I am pleased to welcome David Dennison as our next head of investor relations,” said Agustin Izquierdo, executive vice president and chief financial officer. “His significant experience in global petrochemical markets will help us continue to shape investor understanding and foster clear, two-way engagement with the shareholder community.” David Dennison joined LYB in 2007, and in total brings nearly 30 years of industry experience to the role. He has held leadership roles across the company’s planning, commercial...

Extendicare Announces March 2026 Dividend of C$0.0441 per Share

Written by Customer Service on March 16, 2026. Posted in Dividend Reports And Estimates.

MARKHAM, Ontario, March 16, 2026 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of March 2026, which is payable on April 15, 2026 to shareholders of record at the close of business on March 31, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We operate...

Monarch Private Capital Accelerates Impact in 2026 with Scaled Platforms and Disciplined Growth

Written by Customer Service on March 16, 2026. Posted in Dividend Reports And Estimates.

Investing Across Sectors to Deliver Community ImpactMonarch Private Capital’s investments support projects that strengthen communities nationwide—from utility-scale renewable energy and workforce housing to historic preservation and media infrastructure.ATLANTA, March 16, 2026 (GLOBE NEWSWIRE) — Monarch Private Capital, a national leader in tax equity impact investing, enters 2026 positioned for its next phase of disciplined growth—scaling proven platforms across energy, affordable housing, historic rehabilitation, and film while continuing to deliver predictable outcomes for investors and measurable benefits for communities nationwide. Impact at Scale Since 2005, Monarch has managed tax equity investments generating more than $9 billion in tax credits and supporting more than $23 billion in project development costs. These...

SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

Written by Customer Service on March 16, 2026. Posted in Public Companies.

TEL AVIV, Israel, March 16, 2026 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system (CNS) disorders, in which SciSparc holds a controlling interest of approximately 75%, has reported that pursuant to NeuroThera’s ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”), a patent application has been filed by Clearmind with the Intellectual Property Department in Hong Kong, China, for a innovative combination therapy designed to treat major depressive disorder (MDD). This innovative treatment combines Clearmind’s proprietary 5-methoxy-2-aminoindane (MEAI) with Palmitoylethanolamide (PEA) sourced by NeuroThera. The...

Osisko Development Announces Inclusion in the GDXJ

Written by Customer Service on March 16, 2026. Posted in Public Companies.

MONTREAL, March 16, 2026 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce its inclusion in the VanEck Junior Gold Miners ETF (“GDXJ“) pursuant to the GDXJ’s semi-annual review and rebalancing announced on March 13, 2026, effective at the close of markets on March 20, 2026. “We are very pleased to be included in the widely followed GDXJ index, which we believe will further elevate our market visibility and trading liquidity profile while broadening access to investors seeking exposure to the gold sector,” stated Sean Roosen, Chairman and CEO. “This inclusion reflects the significant progress and milestones our team has achieved to date as we continue advancing and de-risking our flagship Cariboo...

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

Written by Customer Service on March 16, 2026. Posted in Public Companies.

DUBLIN and BRIDGEWATER, N.J., March 16, 2026 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced that additional REDUCE-IT patient subgroup analysis and additional mechanistic data on potential multifactorial biologic activities will be presented at the American College of Cardiology’s Annual Scientific Session & Expo, March 28-30, 2026, in New Orleans, LA. Featured Amarin-supported abstracts to be presented by academic collaborators (italicized below) at ACC Scientific Sessions 2026 include: Oral PresentationEfficacy of Icosapent Ethyl Among Patients at Extreme Cardiovascular Risk: A Secondary Analysis of REDUCE-ITRahul Aggarwal, Deepak L. Bhatt, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven Ketchum,...

Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility

Written by Customer Service on March 16, 2026. Posted in Public Companies.

COPENHAGEN, Denmark – March 16, 2026. Novonesis has completed a EUR 1.7 billion bond issuance, with significant interest from a broad group of investors. The transaction was primarily undertaken to refinance the bridge facility related to Novonesis’ purchase of the dsm firmenich’s part in the Feed Enzyme Alliance, closed in June 2025. The acquisition gives Novonesis full control of the alliance’s sales and distribution, strengthening the company’s position across the animal biosolutions value chain. Rainer Lehmann, CFO: “The significant interest from investors reflects confidence in Novonesis, our business model and the strategic direction we have set for the company. We remain well-positioned to capture growth opportunities in the years ahead.” Transaction detailsNovonesis, through Novozymes A/S, has successfully priced and closed...

Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session

Written by Customer Service on March 16, 2026. Posted in Public Companies.

MONTREAL and CHARLOTTE, N.C., March 16, 2026 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that a moderated poster presentation titled “Minimal Blood Pressure Effects of Intranasal Etripamil in Trials for Paroxysmal Supraventricular Tachycardia (PSVT)” will be featured at the 2026 American College of Cardiology Annual Scientific Session (ACC.26), March 28-30th in New Orleans, La. An Expert Theater will also be conducted at ACC.26, providing a deeper look at this new treatment option for adults with symptomatic PSVT. “Although potential hypotension is a known class effect of calcium channel blockers, this analysis from Milestone’s etripamil Phase 3 program shows that etripamil had...

Millions Locked Out of Banking May Soon Find an Alternative at the Checkout Line. Alpha Cash Plans to Be That Alternative

Written by Customer Service on March 16, 2026. Posted in Public Companies.

With a retail deployment beginning in Texas already planned, the Alpha Cash app and kiosk network are designed to deliver check cashing, money transfers, bill pay, remittance, and prepaid debit access for consumers underserved by traditional banking.Alpha Cash Retail Financial Services KioskA consumer interacts with an Alpha Cash retail kiosk, part of the company’s platform designed to provide check cashing, bill pay, money transfers, and prepaid debit access for underbanked consumers.CORNELIUS, N.C., March 16, 2026 (GLOBE NEWSWIRE) — An estimated 5.6 million U.S. households in America remain unbanked. In Harris County, Texas, alone, that figure approaches 600,000 residents — nearly one in six adults. For many, cashing a paycheck still means standing in line at a grocery or convenience store and paying fees that can reach...

Aspen Group Reports Fourth Consecutive Quarter of Net Income for Third Quarter Fiscal 2026

Written by Customer Service on March 16, 2026. Posted in Earnings Releases And Operating Results.

Q3 Fiscal 2026 Highlights (compared to Q3 Fiscal year 2025)Record net income of $1.4 million versus net loss of $(1.0) million in Q3 FY2025 Operating expenses reduced 18% year-over-year, driving operating income of $1.7 million and 17% operating margin Adjusted EBITDA of $3.0 million (29% margin), up from $1.7 million (15% margin) in the prior-year quarter 2 Fifth consecutive quarter of positive operating cash flow, reaching $1.0 millionPHOENIX, March 16, 2026 (GLOBE NEWSWIRE) — Aspen Group, Inc. (OTCQB: ASPU) (“AGI” or the “Company”), an education technology holding company, today announced financial results for its third quarter of fiscal year 2026 ended January 31, 2026. Third Quarter Fiscal Year 2026 Summary Results Three Months Ended January 31, Nine Months Ended January 31,$ in millions, except per share data...

Day: March 16, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals